916 related articles for article (PubMed ID: 19479488)
1. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
[TBL] [Abstract][Full Text] [Related]
2. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
[TBL] [Abstract][Full Text] [Related]
3. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
[TBL] [Abstract][Full Text] [Related]
4. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic oophorectomy in women at increased cancer risk.
Domchek SM; Rebbeck TR
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
[TBL] [Abstract][Full Text] [Related]
6. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
Michelsen TM; Dørum A; Dahl AA
Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
[TBL] [Abstract][Full Text] [Related]
7. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Madalinska JB; Hollenstein J; Bleiker E; van Beurden M; Valdimarsdottir HB; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2005 Oct; 23(28):6890-8. PubMed ID: 16129845
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review.
Finch A; Narod SA
Maturitas; 2011 Nov; 70(3):261-5. PubMed ID: 21893388
[TBL] [Abstract][Full Text] [Related]
9. Type of menopause, patterns of hormone therapy use, and hot flashes.
Gallicchio L; Whiteman MK; Tomic D; Miller KP; Langenberg P; Flaws JA
Fertil Steril; 2006 May; 85(5):1432-40. PubMed ID: 16566933
[TBL] [Abstract][Full Text] [Related]
10. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale.
Sierra B; Hidalgo LA; Chedraui PA
Maturitas; 2005 Jul; 51(3):236-45. PubMed ID: 15978967
[TBL] [Abstract][Full Text] [Related]
11. Associated factors with urogenital score in natural and surgical menopause.
Hassa H; Tanir HM; Yildirim A; Senses T; Oge T; Mutlu FS
Maturitas; 2005 Sep; 52(1):65-9. PubMed ID: 16143227
[TBL] [Abstract][Full Text] [Related]
12. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Lubsen-Brandsma L; Massuger LF; Mourits MJ; Gaarenstroom KN; van Dorst EB; van der Putten H; Boonstra H; Aaronson NK
J Clin Oncol; 2007 Jan; 25(3):301-7. PubMed ID: 17235045
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy.
Aziz A; Bergquist C; Brännström M; Nordholm L; Silfverstolpe G
Acta Obstet Gynecol Scand; 2005 Sep; 84(9):854-9. PubMed ID: 16097975
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
Stadberg E; Mattsson LA; Milsom I
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):286-92. PubMed ID: 10746844
[TBL] [Abstract][Full Text] [Related]
16. Malignancies following bilateral salpingo-oophorectomy (BSO).
Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
[TBL] [Abstract][Full Text] [Related]
17. High-order maternity may be a more significant determinant of quality of midlife than some of the climacteric symptoms.
Haimov-Kochman R; Brzezinski A; Hochner-Celnikier D
Menopause; 2011 Jun; 18(6):670-4. PubMed ID: 21242817
[TBL] [Abstract][Full Text] [Related]
18. The menopausal experience among indigenous women of Sarawak, Malaysia.
Syed Alwi SA; Lee PY; Awi I; Mallik PS; Md Haizal MN
Climacteric; 2009 Dec; 12(6):548-56. PubMed ID: 19905907
[TBL] [Abstract][Full Text] [Related]
19. Variations in blood lipid profile, thrombotic system, arterial elasticity and psychosexual parameters in the cases of surgical and natural menopause.
Tuna V; Alkiş I; Safiye AS; Imamoglu N; Bayram N; Ali Ismet T
Aust N Z J Obstet Gynaecol; 2010 Apr; 50(2):194-9. PubMed ID: 20522080
[TBL] [Abstract][Full Text] [Related]
20. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
Finch A; Metcalfe KA; Chiang JK; Elit L; McLaughlin J; Springate C; Demsky R; Murphy J; Rosen B; Narod SA
Gynecol Oncol; 2011 Apr; 121(1):163-8. PubMed ID: 21216453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]